Use access key #2 to skip to page content.
$50.38 0.11 (0.22%)
7/8/2008 4:00 PM

Amgen, Inc. (AMGN)

CAPS Rating:
****

A biotechnology company whcih discovers, develops, manufactures and markets human therapeutics based on advances in cellular and molecular biology.

View All Commentary (AMGN)

Recs

0

Avatar BobLangley (50.81) Submitted: 5/02/08 12:29 AM : Outperform Start Price: $43.41 AMGN Score: 25.99

If drugs in the pipeline help AMGN return to anything like its historical P/E ratio, it should do much better than it currently is.

Report this Post Replies: 0 | Reply

Featured Broker Partners